- Home
- TEVA vs LYV Comparison
TEVA vs LYV Comparison
Compare TEVA & LYV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TEVA | LYV |
|---|---|---|
| Founded | 1901 | 2005 |
| Country | Israel | United States |
| Employees | 32842 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.7B | 38.9B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | TEVA | LYV |
|---|---|---|
| Price | $29.66 | $149.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 20 |
| Target Price | $37.38 | ★ $181.05 |
| AVG Volume (30 Days) | ★ 6.7M | 2.6M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,201,406,000.00 |
| Revenue This Year | N/A | $10.17 |
| Revenue Next Year | $2.51 | $9.31 |
| P/E Ratio | $28.19 | ★ N/A |
| Revenue Growth | N/A | ★ 8.83 |
| 52 Week Low | $12.47 | $113.20 |
| 52 Week High | $37.35 | $175.25 |
Technical Indicators
Market Signals| Indicator | TEVA | LYV |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 43.12 |
| Support Level | $28.38 | $149.02 |
| Resistance Level | $31.99 | $157.13 |
| Average True Range (ATR) | 0.99 | 4.86 |
| MACD | -0.02 | -1.31 |
| Stochastic Oscillator | 42.11 | 9.88 |
Price Performance
Historical ComparisonAbout TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About LYV Live Nation Entertainment Inc.
Live Nation is the largest live entertainment company in the world, serving as a concert promoter, venue operator, and ticketing platform. In addition, the firm generates revenue from sponsorships and advertising. With offices in 51 countries, Live Nation promotes concerts globally and it owned, operated, or had exclusive booking rights to more than 400 venues worldwide at the end of 2025, which the firm says makes it the second-largest operator of music venues globally. In 2025, Live Nation promoted nearly 55,000 events, drawing roughly 160 million fans. Ticketmaster is a dominant global ticketing service, selling nearly 650 million tickets in 2025.